• Something wrong with this record ?

Regulation of drug transporter expression and function in the placenta

F. Staud, M. Ceckova,

. 2015 ; 11 (4) : 533-55. [pub] 20150120

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

INTRODUCTION: Medication of pregnant women is increasingly common in developed countries. Several placental drug transporters have been shown to transfer their substrates from the trophoblast back to the maternal circulation, thus hindering the transplacental passage of xenobiotics and protecting the fetus. However, the expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. In addition, their function can be compromised by pathological conditions and/or drug-drug interactions. AREAS COVERED: This article reviews current knowledge on placental drug transporters, their effects on placental pharmacokinetics and the regulatory mechanisms that control their expression and activity. Transcriptional, genetic and epigenetic mechanisms of placental transporter regulation and the drug-drug interactions that modulate transporter activity are described. Physiological and pathological factors that can affect drug transporter expression and function in the placenta are also discussed. EXPERT OPINION: The expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. Subsequently, there is a great variability in the expression and function of placental drug transporters both within human populations (interindividual variability) and also during gestation (intraindividual variability). An understanding of the expression and function of placental drug transporters is essential for efficient and safe therapy during pregnancy. There is clearly a need for further preclinical and clinical studies on placental drug transporters, but such investigations must be carefully designed and the resulting data should be evaluated with great caution. This review highlights several methodological aspects that will have to be considered and addressed in order to shed further light on these important issues.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000367
003      
CZ-PrNML
005      
20160125111357.0
007      
ta
008      
160108s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1517/17425255.2015.1005073 $2 doi
035    __
$a (PubMed)25600150
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Staud, Frantisek $u Charles University in Prague, Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove , Heyrovskeho 1203, 50005 Hradec Kralove , Czech Republic +420 495 067 407 ; +420 495 067 170 ; frantisek.staud@faf.cuni.cz.
245    10
$a Regulation of drug transporter expression and function in the placenta / $c F. Staud, M. Ceckova,
520    9_
$a INTRODUCTION: Medication of pregnant women is increasingly common in developed countries. Several placental drug transporters have been shown to transfer their substrates from the trophoblast back to the maternal circulation, thus hindering the transplacental passage of xenobiotics and protecting the fetus. However, the expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. In addition, their function can be compromised by pathological conditions and/or drug-drug interactions. AREAS COVERED: This article reviews current knowledge on placental drug transporters, their effects on placental pharmacokinetics and the regulatory mechanisms that control their expression and activity. Transcriptional, genetic and epigenetic mechanisms of placental transporter regulation and the drug-drug interactions that modulate transporter activity are described. Physiological and pathological factors that can affect drug transporter expression and function in the placenta are also discussed. EXPERT OPINION: The expression and activity of drug transporter proteins in the placenta vary during gestation and are tightly regulated by many factors. Subsequently, there is a great variability in the expression and function of placental drug transporters both within human populations (interindividual variability) and also during gestation (intraindividual variability). An understanding of the expression and function of placental drug transporters is essential for efficient and safe therapy during pregnancy. There is clearly a need for further preclinical and clinical studies on placental drug transporters, but such investigations must be carefully designed and the resulting data should be evaluated with great caution. This review highlights several methodological aspects that will have to be considered and addressed in order to shed further light on these important issues.
650    _2
$a zvířata $7 D000818
650    _2
$a biologický transport $x fyziologie $7 D001692
650    _2
$a lékové interakce $7 D004347
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a maternofetální výměna látek $x fyziologie $7 D008431
650    _2
$a membránové transportní proteiny $x genetika $x metabolismus $7 D026901
650    _2
$a placenta $x metabolismus $7 D010920
650    _2
$a těhotenství $7 D011247
650    _2
$a xenobiotika $x škodlivé účinky $x farmakokinetika $7 D015262
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Ceckova, Martina
773    0_
$w MED00183846 $t Expert opinion on drug metabolism & toxicology $x 1744-7607 $g Roč. 11, č. 4 (2015), s. 533-55
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25600150 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20160125111519 $b ABA008
999    __
$a ok $b bmc $g 1102648 $s 924573
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 11 $c 4 $d 533-55 $e 20150120 $i 1744-7607 $m Expert opinion on drug metabolism & toxicology $n Expert Opin Drug Metab Toxicol $x MED00183846
LZP    __
$a Pubmed-20160108

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...